IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK B ODANIEL

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1164529640
CMS profile
510418
Location
ROCKY MOUNT, NC

General Payments · PY2018–2024

$39,343.01

  • Reported across 335 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,632.35

48 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry NC All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,750.00 1
Food and Beverage $592.99 43
Education $200.25 3
Travel and Lodging $89.11 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $1,862.09 4
Teva Pharmaceuticals USA, Inc. $333.08 22
Janssen Pharmaceuticals, Inc $147.89 7
Otsuka America Pharmaceutical, Inc. $71.49 4
ITI, Inc. $69.87 4
E.R. Squibb & Sons, L.L.C. $59.81 3
Vanda Pharmaceuticals Inc. $39.28 2
Indivior Inc. $34.35 1
Neurocrine BioSciences, Inc. $14.49 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $10,157.11 58
PY2019 $3,217.40 62
PY2020 $2,916.81 21
PY2021 $2,915.63 31
PY2022 $3,967.36 48
PY2023 $13,536.35 67
PY2024 $2,632.35 48

Payment records · PY2024 (48)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $8.52 01/08/2024 Food and Beverage Undisputed 01/23/2026 1105145184 CMS
ABBVIE INC. $89.11 02/20/2024 Travel and Lodging Undisputed 01/23/2026 1105145186 CMS
ABBVIE INC. $1,750.00 03/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105145188 CMS
ABBVIE INC. $14.46 07/24/2024 Food and Beverage Undisputed 01/23/2026 1105145190 CMS
E.R. Squibb & Sons, L.L.C. $27.27 10/09/2024 Education Undisputed 01/23/2026 1101278085 CMS
E.R. Squibb & Sons, L.L.C. $15.42 11/18/2024 Food and Beverage Undisputed 01/23/2026 1101278105 CMS
E.R. Squibb & Sons, L.L.C. $17.12 12/16/2024 Food and Beverage Undisputed 01/23/2026 1101278113 CMS
Indivior Inc. $34.35 07/02/2024 Food and Beverage Undisputed 01/23/2026 1144534607 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.47 01/10/2024 Food and Beverage Undisputed 01/23/2026 1143288973 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.42 02/28/2024 Food and Beverage Undisputed 01/23/2026 1143288977 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.26 07/23/2024 Food and Beverage Undisputed 01/23/2026 1143288981 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.72 09/17/2024 Food and Beverage Undisputed 01/23/2026 1143288984 CMS
Janssen Pharmaceuticals, Inc $20.21 01/22/2024 Food and Beverage Undisputed 01/23/2026 1078082052 CMS
Janssen Pharmaceuticals, Inc $20.21 03/26/2024 Food and Beverage Undisputed 01/23/2026 1078082122 CMS
Janssen Pharmaceuticals, Inc $5.94 04/29/2024 Food and Beverage Undisputed 01/23/2026 1078082088 CMS
Janssen Pharmaceuticals, Inc $32.39 06/04/2024 Food and Beverage Undisputed 01/23/2026 1078082078 CMS
Janssen Pharmaceuticals, Inc $15.79 10/23/2024 Food and Beverage Undisputed 01/23/2026 1078082054 CMS
Janssen Pharmaceuticals, Inc $29.87 11/24/2024 Food and Beverage Undisputed 01/23/2026 1078082074 CMS
Janssen Pharmaceuticals, Inc $23.48 12/09/2024 Food and Beverage Undisputed 01/23/2026 1078082064 CMS
Neurocrine Biosciences, Inc. $14.49 08/20/2024 Food and Beverage Undisputed 01/23/2026 1150876376 CMS
Otsuka America Pharmaceutical, Inc. $19.72 03/18/2024 Food and Beverage Undisputed 01/23/2026 1118953422 CMS
Otsuka America Pharmaceutical, Inc. $14.85 04/16/2024 Food and Beverage Undisputed 01/23/2026 1118953424 CMS
Otsuka America Pharmaceutical, Inc. $19.09 07/29/2024 Food and Beverage Undisputed 01/23/2026 1118953426 CMS
Otsuka America Pharmaceutical, Inc. $17.83 12/09/2024 Food and Beverage Undisputed 01/23/2026 1118953428 CMS
Teva Pharmaceuticals USA, Inc. $4.61 02/13/2024 Food and Beverage Undisputed 01/23/2026 1151598569 CMS
Teva Pharmaceuticals USA, Inc. $2.25 03/11/2024 Food and Beverage Undisputed 01/23/2026 1151598577 CMS
Teva Pharmaceuticals USA, Inc. $7.82 03/11/2024 Food and Beverage Undisputed 01/23/2026 1151598579 CMS
Teva Pharmaceuticals USA, Inc. $12.81 03/12/2024 Food and Beverage Undisputed 01/23/2026 1151598581 CMS
Teva Pharmaceuticals USA, Inc. $7.22 04/08/2024 Food and Beverage Undisputed 01/23/2026 1151598591 CMS
Teva Pharmaceuticals USA, Inc. $12.05 04/23/2024 Food and Beverage Undisputed 01/23/2026 1151598593 CMS
Teva Pharmaceuticals USA, Inc. $9.60 05/07/2024 Food and Beverage Undisputed 01/23/2026 1151598599 CMS
Teva Pharmaceuticals USA, Inc. $13.70 06/10/2024 Food and Beverage Undisputed 01/23/2026 1151598609 CMS
Teva Pharmaceuticals USA, Inc. $8.81 06/18/2024 Food and Beverage Undisputed 01/23/2026 1151598613 CMS
Teva Pharmaceuticals USA, Inc. $7.34 06/24/2024 Food and Beverage Undisputed 01/23/2026 1151598615 CMS
Teva Pharmaceuticals USA, Inc. $6.34 07/30/2024 Food and Beverage Undisputed 01/23/2026 1151598617 CMS
Teva Pharmaceuticals USA, Inc. $61.49 07/31/2024 Education Undisputed 01/23/2026 1151598625 CMS
Teva Pharmaceuticals USA, Inc. $6.68 08/12/2024 Food and Beverage Undisputed 01/23/2026 1151598623 CMS
Teva Pharmaceuticals USA, Inc. $111.49 09/09/2024 Education Undisputed 01/23/2026 1151598627 CMS
Teva Pharmaceuticals USA, Inc. $11.75 09/10/2024 Food and Beverage Undisputed 01/23/2026 1151598631 CMS
Teva Pharmaceuticals USA, Inc. $11.75 09/24/2024 Food and Beverage Undisputed 01/23/2026 1151598633 CMS
Teva Pharmaceuticals USA, Inc. $6.80 09/30/2024 Food and Beverage Undisputed 01/23/2026 1151598665 CMS
Teva Pharmaceuticals USA, Inc. $9.21 10/08/2024 Food and Beverage Undisputed 01/23/2026 1151598667 CMS
Teva Pharmaceuticals USA, Inc. $7.21 10/21/2024 Food and Beverage Undisputed 01/23/2026 1151598669 CMS
Teva Pharmaceuticals USA, Inc. $3.59 10/22/2024 Food and Beverage Undisputed 01/23/2026 1151598691 CMS
Teva Pharmaceuticals USA, Inc. $7.29 11/11/2024 Food and Beverage Undisputed 01/23/2026 1151598693 CMS
Teva Pharmaceuticals USA, Inc. $3.27 12/10/2024 Food and Beverage Undisputed 01/23/2026 1151598699 CMS
Vanda Pharmaceuticals Inc. $19.75 01/24/2024 Food and Beverage Undisputed 01/23/2026 1133914669 CMS
Vanda Pharmaceuticals Inc. $19.53 03/20/2024 Food and Beverage Undisputed 01/23/2026 1133914671 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.